PRTA Q4 2017 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$512M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$229,000+33.9% YoY

Gross Profit

-$33M-14529.7% margin

Operating Income

-$47M-20662.4% margin

Net Income

-$48M-20855.0% margin

EPS (Diluted)

$-1.24

QoQ Revenue Growth

+4.6%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$40M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$496M

Total Liabilities

$89M

Stockholders' Equity

$407M

Cash & Equivalents

$418M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$229,000	$171,000	+33.9%
Gross Profit	-$33M	-$40M	+16.1%
Operating Income	-$47M	-$49M	+4.0%
Net Income	-$48M	-$49M	+2.3%